Prior authorization (PA) requirements for patients undergoing primary total hip arthroplasty did not reduce costs, but did ...

There were no sex-related differences in-hospital mortality after elective primary total hip arthroplasty for osteoarthritis.

SAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring ...

The Mexborough Elective Orthopaedic Centre of Excellence (MEOC) has reached an impressive milestone this month, completing ...

Stopping GLP-1 RA treatment 14 days before total joint arthroplasty can minimize risks for complications, according to study findings.

Spouses of patients undergoing total joint arthroplasty see a significant improvement in their own quality of life, according to a study presented at the annual meeting of the American Academy of ...

Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report ...

Results presented here showed patients who had significant weight loss prior to total hip arthroplasty with use of a GLP-1 receptor agonist experienced a decreased risk for complications but an ...

Shoulder Innovations has secured $40m in a Series E equity financing round, to mainly progress the commercialisation of its InSet Total Shoulder and Reverse Shoulder Arthroplasty Systems.

While commercial insurers often use prior authorization as a way to control costs, it does the opposite for patients undergoing total hip arthroplasty, according to a study presented at the 2025 ...